{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:17:10Z","timestamp":1781723830227,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian Research Council Discovery Project","award":["DP140100591"],"award-info":[{"award-number":["DP140100591"]}]},{"name":"Australian Research Council Discovery Linkage Infrastructure Equipment Facility","award":["LE0668439"],"award-info":[{"award-number":["LE0668439"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jpba.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T18:01:14Z","timestamp":1428516074000},"page":"222-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry"],"prefix":"10.1016","volume":"111","author":[{"given":"Patrick","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Downard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.03.014_bib0220","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jpba.2015.03.014_bib0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jpba.2015.03.014_bib0230","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"Yen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.03.014_bib0235","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.03.014_bib0240","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2015.03.014_bib0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2015.03.014_bib0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo","volume":"55","author":"Ives","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0255","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/651605","article-title":"Rapid selection of oseltamivir and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts","volume":"50","author":"Memoli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2015.03.014_bib0260","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMp0910479","article-title":"The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza","volume":"361","author":"Birnkrant","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2015.03.014_bib0265","series-title":"Oseltamivir Resistance Weekly Update, Factsheet","author":"World Heath Organization","year":"2010"},{"key":"10.1016\/j.jpba.2015.03.014_bib0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2004.02.034","article-title":"Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors","volume":"103","author":"Gubareva","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0275","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3201\/eid1711.110787","article-title":"Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010\u201311","volume":"17","author":"Sleeman","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jpba.2015.03.014_bib0280","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/eri.12.125","article-title":"Influenza antivirals and resistance: the next 10 years?","volume":"10","author":"Hurt","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.jpba.2015.03.014_bib0285","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series","volume":"193","author":"Ison","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jpba.2015.03.014_bib0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2015.03.014_bib0295","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nsmb.1909","article-title":"The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ncomms1390","article-title":"Mechanism of 150-cavity formation in influenza neuraminidase","volume":"2","author":"Amaro","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2015.03.014_bib0305","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1007\/s00216-013-7068-x","article-title":"Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry","volume":"405","author":"Swaminathan","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2015.03.014_bib0310","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.00638-11","article-title":"Influenza A virus N5 neuraminidase has an extended 150-cavity","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.aca.2014.04.021","article-title":"Substituent effects on the binding of natural product anthocyanidin inhibitors to influenza neuraminidase with mass spectrometry","volume":"828","author":"Swaminathan","year":"2013","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2015.03.014_bib0320","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1021\/ac9811120","article-title":"Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody-peptide complexes","volume":"71","author":"Kiselar","year":"1999","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2015.03.014_bib0325","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.1021\/bi991609j","article-title":"Antigenic surveillance of the influenza virus by mass spectrometry","volume":"38","author":"Kiselar","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpba.2015.03.014_bib0330","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/pmic.200500642","article-title":"A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry","volume":"6","author":"Morrissey","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jpba.2015.03.014_bib0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15321810903084350","article-title":"Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays","volume":"30","author":"Schwahn","year":"2009","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.jpba.2015.03.014_bib0340","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1021\/ac300291c","article-title":"Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry","volume":"84","author":"Swaminathan","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2015.03.014_bib0345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.antiviral.2013.08.021","article-title":"Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry","volume":"100","author":"Nasser","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0350","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","article-title":"Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells","volume":"46","author":"Imanishi","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0355","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0360","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2007.07.001","article-title":"Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives","volume":"76","author":"Song","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0365","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.antiviral.2013.08.002","article-title":"Inhibition of influenza virus internalization by (\u2212)-epigallocatechin-3-gallate","volume":"100","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0370","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/v5010352","article-title":"Influenza A virus entry inhibitors targeting the hemagglutinin","volume":"5","author":"Yang","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.jpba.2015.03.014_bib0375","doi-asserted-by":"crossref","first-page":"RRN1052","DOI":"10.1371\/currents.RRN1052","article-title":"Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase","volume":"1","author":"Kuzuhara","year":"2009","journal-title":"PLoS Curr."},{"key":"10.1016\/j.jpba.2015.03.014_bib0380","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.antiviral.2013.08.002","article-title":"Inhibition of influenza virus internalization by (\u2212)-epigallocatechin-3-gallate","volume":"100","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.fitote.2013.12.011","article-title":"Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure\u2013activity relationship analysis","volume":"93","author":"Yang","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jpba.2015.03.014_bib0390","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C1NP00053E","article-title":"Influenza neuraminidase: a druggable target for natural products","volume":"29","author":"Grienke","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jpba.2015.03.014_bib0395","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.antiviral.2011.12.006","article-title":"In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03","volume":"93","author":"Kim","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2015.03.014_bib0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-1759(88)90149-4","article-title":"A highly reliable, sensitive, flow cytometric\/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells","volume":"114","author":"Schols","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2015.03.014_bib0405","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.79.18.11705-11715.2005","article-title":"Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication","volume":"79","author":"Suzuki","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0410","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9","article-title":"FindPept, a tool to identify unmatched masses in peptide mass fingerprinting protein identification","volume":"2","author":"Gattiker","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.jpba.2015.03.014_bib0415","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jasms.2006.11.005","article-title":"A computer algorithm for the identification of protein interactions from the spectra of masses (PRISM)","volume":"18","author":"Ho","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2015.03.014_bib0420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00418-002-0399-x","article-title":"Fluorescent cytochemical detection of sialidase activity using 5-bromo-4-chloroindol-3-yl-alphaD-N-acetylneuraminic acid as the substrate","volume":"117","author":"Saito","year":"2002","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0425","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00705-012-1304-0","article-title":"Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus","volume":"157","author":"Chen","year":"2012","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jpba.2015.03.014_bib0430","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3851\/IMP1774","article-title":"Epigallocatechin gallate inhibits the HIV reverse transcription step","volume":"21","author":"Li","year":"2012","journal-title":"Antivir. Chem. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:21:20Z","timestamp":1566519680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":43,"alternative-id":["S0731708515001910"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.03.014","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}